Adverse events with transvenous implantable cardioverter-defibrillators: a prospective multicenter study. European 7219 Jewel ICD investigators.
about
2015 ESC Guidelines for the management of patients with ventricular arrhythmias and the prevention of sudden cardiac death: The Task Force for the Management of Patients with Ventricular Arrhythmias and the Prevention of Sudden Cardiac Death of theRemote monitoring in implantable defibrillator therapy.Three-dimensional computed tomography imaging of an implantable cardioverter-defibrillator lead fragment in the left ventricle of a heart transplant followed by successful transarterial extraction with a snare catheter.The implantable cardioverter-defibrillator.High incidence of appropriate and inappropriate ICD therapies in children and adolescents with implantable cardioverter defibrillator.Supraventricular arrhythmia induction by an implantable cardioverter defibrillator in a patient with hypertrophic cardiomyopathy.The use of implantable cardioverter defibrillators in Iceland: a retrospective population based study.Implantable dual-chamber cardioverter-defibrillator-pacemaker.Methods of minimizing inappropriate implantable cardioverter-defibrillator shocks.The frequency and incremental cost of major complications among medicare beneficiaries receiving implantable cardioverter-defibrillators.Cardiac ablation catheter guidance by means of a single equivalent moving dipole inverse algorithm.ECG-derived spatial QRS-T angle is associated with ICD implantation, mortality and heart failure admissions in patients with LV systolic dysfunction.2015 HRS/EHRA/APHRS/SOLAECE expert consensus statement on optimal implantable cardioverter-defibrillator programming and testing.Clinical benefit, survival and adverse events in patients with implantable cardioverter defibrillators: the initial Rotterdam experience.Implantable cardioverter defibrillator therapy and the need for concomitant antiarrhythmic drugs.Views of patients with heart failure about their role in the decision to start implantable cardioverter defibrillator treatment: prescription rather than participation.Remote monitoring of patients with biventricular defibrillators through the CareLink system improves clinical management of arrhythmias and heart failure episodes.Depression in patients with heart failure: clinical implications and management.Computational cardiology and risk stratification for sudden cardiac death: one of the grand challenges for cardiology in the 21st century.Implantable cardioverter defibrillator-related complications in the pediatric population.Feasibility and safety of same-day discharge after implantable cardioverter defibrillator placement for primary prevention.Integrated approach for smart implantable cardioverter defibrillator (ICD) device with real time ECG monitoring: use of flexible sensors for localized arrhythmia sensing and stimulation.Advances in implantable cardioverter defibrillator therapy.Implantable cardioverter defibrillator management: an update.Why We Need Postmortem Analysis of Cardiac Implantable Electronic Devices.Long-term outcome of patients who received implantable cardioverter defibrillators for stable ventricular tachycardia.Patients with implantable cardioverter-defibrillators and their conceptions of the life situation: a qualitative analysis.Implantable cardioverter defibrillator therapy: a single center experience in saudi arabia.Complications and mortality of single versus dual chamber implantable cardioverter defibrillatorsVentricular arrhythmia discriminator programming and the impact on the incidence of inappropriate therapy in patients with implantable cardiac defibrillators.Death due to an implantable cardioverter defibrillator.Mechanisms of inappropriate defibrillator therapy in a modern cohort of remotely monitored patients.Single-chamber ICD, single-zone therapy in primary and secondary prevention patients: the simpler the better?Safety and potential cost savings of same-setting electrophysiologic testing and placement of transvenous implantable cardioverter-defibrillators.Analysis of implantable cardioverter defibrillator therapy in the Antiarrhythmics Versus Implantable Defibrillators (AVID) Trial.Electrocardiographic left ventricular hypertrophy predicts arrhythmia and mortality in patients with ischemic cardiomyopathy.Indications and outcome of implantable cardioverter-defibrillators for primary and secondary prophylaxis in patients with noncompaction cardiomyopathy.Clinical results of an advanced SVT detection enhancement algorithm.Natural History of Implantable Cardioverter-Defibrillator Implanted at or after the Age of 70 years in a Veteran Population: A Single Center Study.Mortality, morbidity, and complications in 3344 patients with implantable cardioverter defibrillators: results fron the German ICD Registry EURID.
P2860
Q28087002-52A07E9C-AC5D-4338-8555-2DADAF0A00A1Q30496677-AFABD1D5-791B-45FA-998D-CC30486F0735Q30517784-148D1E5D-6781-4E53-B5E7-E5832E78CE0EQ33145454-B53B6B3F-E2F0-4728-B405-42AC41E8CE70Q33151605-C968AB45-03A9-412E-82D5-F2212D1DE550Q33157788-448BA99B-601A-4706-BDD3-AEA0442555E8Q33244602-7610C25D-7864-4C86-82D5-7FAB83C414AFQ34011210-6F1FED0D-0DE2-48F4-9F5F-C28838B9812BQ34011215-DD128286-9960-428D-AD9D-256EE5161299Q35642193-3C07A28E-07D8-4E70-836B-AC78AAF7CFFFQ36042194-D3550EAE-7819-4C39-8A56-6F4185CB5F1DQ36328047-3B99CD66-AE06-45DA-94C5-0419830FA157Q36594611-5180B6CD-622B-47C1-BD9A-6D8CFFB3542AQ36817131-7F3ECECC-DF96-434B-AD8D-8820A3C94391Q36944481-4E05DDF4-AEC2-4879-A83C-A1F3E9738FBFQ37005120-75CFD2EA-949A-4E29-BFCB-A204F1569BA7Q37313970-90888A08-0F76-4B67-9577-0323A511B896Q37359620-3DC76E38-7C25-4091-A0FD-E298CAC5A676Q37466831-615EA127-A5B1-41A4-8055-BEBCECA1E93DQ37551223-D3986B34-640C-4BB3-8D86-C2C4AF94C26DQ38101629-BF42311E-38DB-4064-BD85-5DA124E377A8Q38156163-6A8F9E01-0CF4-4D2C-8766-3C9B17785F9FQ38665047-DEAEB8A2-8CFB-4D36-A2C1-64129F977905Q38801619-60149582-3B43-462A-9368-3BCB6E47941EQ39641465-9003D6CF-19B4-413F-BF67-4604019BCC8FQ40506611-F20FDAC8-AF53-477B-BFC7-9832E352B7C4Q40744213-BB903A15-EBE6-4E4E-9788-B0DC40D31B3BQ41158368-C9F04B25-624F-42B6-9761-D24762D0FC1FQ41467055-C75235E4-9588-4557-8B48-023846F9A3E5Q42773647-5F2E45A3-89E5-4612-B051-960E4C36A6E9Q43740102-7AD4D2BE-B1B3-40EE-BDB6-89D7D2085898Q43769568-B60CD2D0-0DE0-4BA8-BFBF-1265584A3AA3Q43892315-EB3EA920-39E4-44C0-992F-96DCD3B5D992Q44268676-34370D22-5BC9-4447-85EA-ACBEA545ECFEQ44570095-3BF49CD3-4967-4C01-8F86-F1A942C7B00FQ44800131-C1A7E839-ABE5-4825-B60C-2D8065DA3CE7Q45854608-522C8C82-004F-415F-A03B-DF7DD45EC420Q46474698-861BBCDB-24B8-44C2-8376-6176D5A36698Q47241590-E791099A-865C-4DAC-9B5A-DAD244E91182Q47695480-3FED0741-B1A2-441C-BC15-C336BE23840D
P2860
Adverse events with transvenous implantable cardioverter-defibrillators: a prospective multicenter study. European 7219 Jewel ICD investigators.
description
1998 nî lūn-bûn
@nan
1998年の論文
@ja
1998年学术文章
@wuu
1998年学术文章
@zh
1998年学术文章
@zh-cn
1998年学术文章
@zh-hans
1998年学术文章
@zh-my
1998年学术文章
@zh-sg
1998年學術文章
@yue
1998年學術文章
@zh-hant
name
Adverse events with transvenou ...... 7219 Jewel ICD investigators.
@en
Adverse events with transvenou ...... 7219 Jewel ICD investigators.
@nl
type
label
Adverse events with transvenou ...... 7219 Jewel ICD investigators.
@en
Adverse events with transvenou ...... 7219 Jewel ICD investigators.
@nl
prefLabel
Adverse events with transvenou ...... 7219 Jewel ICD investigators.
@en
Adverse events with transvenou ...... 7219 Jewel ICD investigators.
@nl
P2093
P356
P1433
P1476
Adverse events with transvenou ...... 7219 Jewel ICD investigators.
@en
P2093
P304
P356
10.1161/01.CIR.98.7.663
P407
P577
1998-08-01T00:00:00Z